Marc Steben, Suzanne M Garland
Best Practice & Research Clinical Obstetrics & Gynaecology | ELSEVIER SCI LTD | Published : 2014
Marc Steben has received research, lecture or consultation grants from Merck, Triton and Valeant. Suzanne Marie Garland has received advisory board fees and grant support from CSL and GlaxoSmithKline, and lecture fees from Merck, GSK and Sanofi Pasteur; in addition, she has also received funding through her institution to conduct HPV vaccine studies for MSD and GSK. She is a member of the Merck Global Advisory Board as well as the Merck Scientific Advisory Committee for HPV.